Loading…
for educational and safety purposes
5-MeO-DMT and Bufotenine both come up in the same conversations; they overlap on Serotonin. 5-MeO-DMT: 5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), also known as mebufotenin, is a fast-acting serotonergic psychedelic found in the venom of the Sonoran Desert toad and in numerous plants, as well as produced synthetically. Bufotenine: Bufotenine (5-hydroxy-N,N-dimethyltryptamine) is a naturally occurring tryptamine and a positional isomer of psilocin, found in the seeds of Anadenanthera trees used to make the South American shamanic snuffs yopo and cebil, in the skin secretions of Bufo toads, and in some mushrooms.
5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine), also known as mebufotenin, is a fast-acting serotonergic psychedelic found in the venom of the Sonoran Desert toad and in numerous plants, as well as produced synthetically. It is distinguished among classical psychedelics by pronounced agonism at the 5-HT1A receptor in addition to 5-HT2A, a profile linked to its uniquely intense, short-lived and often ego-dissolving effects. Preclinical work indicates it modulates proteins governing long-term potentiation and dendritic-spine formation in human cerebral organoids, and early-phase clinical trials of a vaporized formulation have reported rapid, sometimes single-day remission in treatment-resistant depression. Owing to its potency and overwhelming acute effects, it carries substantial physiological and psychological risk and is typically used only in carefully controlled settings.
Bufotenine (5-hydroxy-N,N-dimethyltryptamine) is a naturally occurring tryptamine and a positional isomer of psilocin, found in the seeds of Anadenanthera trees used to make the South American shamanic snuffs yopo and cebil, in the skin secretions of Bufo toads, and in some mushrooms. Pharmacologically it is a serotonergic agonist active at 5-HT2A and 5-HT2C receptors, the same receptors engaged by classic hallucinogens, and computational and in vitro studies confirm it can bind and activate them. Its psychoactivity in humans has long been debated, however, because its ionizable 5-hydroxy group limits passage across the blood-brain barrier, so much of an ingested dose acts peripherally; intravenous administration in early human experiments produced profound but very short-lived perceptual and emotional changes. That poor central penetration, combined with strong peripheral cardiovascular and autonomic effects, makes bufotenine a physiologically demanding and higher-risk substance. It is a controlled Schedule I compound.
both fingerprints on one instrument; where the marks line up the two compounds work the same lever, where a slot goes dark only one of them touches it. read straight from each entry's affinity table; nothing here is invented.
agonist
agonist
agonist
agonist
agonist
poor (ionizable 5-hydroxy group)
strengths are the entries' qualitative ratings (strong / moderate / weak); Ki and EC50 figures appear where an entry records them.